Ultrasonic treatment of endocrine disrupting compounds, pharmaceuticals, and personal care products in water: A review

Kyoung Hoon Chu; Yasir A.J. Al-Hamadani; Chang Min Park; Gooyong Lee; Min Jang; Am Jang; Namguk Her; Ahjeong Son; Yeomin Yoon

doi:10.1016/j.cej.2017.06.137

Ultrasonic treatment of endocrine disrupting compounds, pharmaceuticals, and personal care products in water: A review

Kyoung Hoon Chu, Yasir A.J. Al-Hamadani, Chang Min Park, Gooyong Lee, Min Jang, Am Jang, Namguk Her, Ahjeong Son, Yeomin Yoon

Environmental Science & Engineering

Research output: Contribution to journal › Review article › peer-review

120 Scopus citations

Abstract

The presence of contaminants of emerging concerns such as endocrine-disrupting compounds (EDCs) and pharmaceuticals/personal-care products (PPCPs) is of concern because they are not completely removed during conventional water and wastewater (WW) treatment processes including coagulation/flocculation/sedimentation/filtration and biological activated sludge process. Recently, ultrasonic (US) treatment has been well-known as an advanced treatment process for the removal of complex inorganic and organic contaminants in water and WW. US treatment has shown substantial advantages, such as cleanliness, safety, energy savings, and negligible or no secondary pollution products. This review provides a summary of recent research on the removal of EDCs and PPCPs by US treatment and also provides information valuable for applications of US treatment in water and WW treatment. The removal of numerous EDCs and PPCPs of different classes was reviewed based on the current literature to (i) address key factors (water quality conditions (pH, temperature, background common ions, and promoters/scavengers), US frequency, power, and reactor type) influencing the sonodegradation of EDCs and PPCPs and their intermediates during US treatment, (ii) evaluate the effects of various catalysts and hybrid processes on sonodegradation, and (iii) discuss EDC and PPCP removal according to their properties. Additionally, areas of future research in US treatment for the removal of EDCs and PPCPs from water are suggested.

Original language	English
Pages (from-to)	629-647
Number of pages	19
Journal	Chemical Engineering Journal
Volume	327
DOIs	https://doi.org/10.1016/j.cej.2017.06.137
State	Published - 1 Nov 2017

Bibliographical note

Funding Information:
This research was supported by a grant (code 17IFIP-B088091-04) from Industrial Facilities & Infrastructure Research Program funded by Ministry of Land, Infrastructure and Transport of Korean government. This research was also supported by the Korea Ministry of Environment , ‘GAIA Project, 2015000540003’.

Publisher Copyright:
© 2017 Elsevier B.V.

Keywords

Endocrine-disrupting compounds
Pharmaceuticals and personal care products
Sonodegradation
Ultrasonic treatment
Water treatment

Access to Document

10.1016/j.cej.2017.06.137

Cite this

@article{b34fd6c2a89b49458db5a04a39996d0d,

title = "Ultrasonic treatment of endocrine disrupting compounds, pharmaceuticals, and personal care products in water: A review",

abstract = "The presence of contaminants of emerging concerns such as endocrine-disrupting compounds (EDCs) and pharmaceuticals/personal-care products (PPCPs) is of concern because they are not completely removed during conventional water and wastewater (WW) treatment processes including coagulation/flocculation/sedimentation/filtration and biological activated sludge process. Recently, ultrasonic (US) treatment has been well-known as an advanced treatment process for the removal of complex inorganic and organic contaminants in water and WW. US treatment has shown substantial advantages, such as cleanliness, safety, energy savings, and negligible or no secondary pollution products. This review provides a summary of recent research on the removal of EDCs and PPCPs by US treatment and also provides information valuable for applications of US treatment in water and WW treatment. The removal of numerous EDCs and PPCPs of different classes was reviewed based on the current literature to (i) address key factors (water quality conditions (pH, temperature, background common ions, and promoters/scavengers), US frequency, power, and reactor type) influencing the sonodegradation of EDCs and PPCPs and their intermediates during US treatment, (ii) evaluate the effects of various catalysts and hybrid processes on sonodegradation, and (iii) discuss EDC and PPCP removal according to their properties. Additionally, areas of future research in US treatment for the removal of EDCs and PPCPs from water are suggested.",

keywords = "Endocrine-disrupting compounds, Pharmaceuticals and personal care products, Sonodegradation, Ultrasonic treatment, Water treatment",

author = "Chu, {Kyoung Hoon} and Al-Hamadani, {Yasir A.J.} and Park, {Chang Min} and Gooyong Lee and Min Jang and Am Jang and Namguk Her and Ahjeong Son and Yeomin Yoon",

note = "Funding Information: This research was supported by a grant (code 17IFIP-B088091-04) from Industrial Facilities & Infrastructure Research Program funded by Ministry of Land, Infrastructure and Transport of Korean government. This research was also supported by the Korea Ministry of Environment , {\textquoteleft}GAIA Project, 2015000540003{\textquoteright}. Publisher Copyright: {\textcopyright} 2017 Elsevier B.V.",

year = "2017",

month = nov,

day = "1",

doi = "10.1016/j.cej.2017.06.137",

language = "English",

volume = "327",

pages = "629--647",

journal = "Chemical Engineering Journal",

issn = "1385-8947",

publisher = "Elsevier",

}

TY - JOUR

T1 - Ultrasonic treatment of endocrine disrupting compounds, pharmaceuticals, and personal care products in water

T2 - A review

AU - Chu, Kyoung Hoon

AU - Al-Hamadani, Yasir A.J.

AU - Park, Chang Min

AU - Lee, Gooyong

AU - Jang, Min

AU - Jang, Am

AU - Her, Namguk

AU - Son, Ahjeong

AU - Yoon, Yeomin

N1 - Funding Information: This research was supported by a grant (code 17IFIP-B088091-04) from Industrial Facilities & Infrastructure Research Program funded by Ministry of Land, Infrastructure and Transport of Korean government. This research was also supported by the Korea Ministry of Environment , ‘GAIA Project, 2015000540003’. Publisher Copyright: © 2017 Elsevier B.V.

PY - 2017/11/1

Y1 - 2017/11/1

N2 - The presence of contaminants of emerging concerns such as endocrine-disrupting compounds (EDCs) and pharmaceuticals/personal-care products (PPCPs) is of concern because they are not completely removed during conventional water and wastewater (WW) treatment processes including coagulation/flocculation/sedimentation/filtration and biological activated sludge process. Recently, ultrasonic (US) treatment has been well-known as an advanced treatment process for the removal of complex inorganic and organic contaminants in water and WW. US treatment has shown substantial advantages, such as cleanliness, safety, energy savings, and negligible or no secondary pollution products. This review provides a summary of recent research on the removal of EDCs and PPCPs by US treatment and also provides information valuable for applications of US treatment in water and WW treatment. The removal of numerous EDCs and PPCPs of different classes was reviewed based on the current literature to (i) address key factors (water quality conditions (pH, temperature, background common ions, and promoters/scavengers), US frequency, power, and reactor type) influencing the sonodegradation of EDCs and PPCPs and their intermediates during US treatment, (ii) evaluate the effects of various catalysts and hybrid processes on sonodegradation, and (iii) discuss EDC and PPCP removal according to their properties. Additionally, areas of future research in US treatment for the removal of EDCs and PPCPs from water are suggested.

AB - The presence of contaminants of emerging concerns such as endocrine-disrupting compounds (EDCs) and pharmaceuticals/personal-care products (PPCPs) is of concern because they are not completely removed during conventional water and wastewater (WW) treatment processes including coagulation/flocculation/sedimentation/filtration and biological activated sludge process. Recently, ultrasonic (US) treatment has been well-known as an advanced treatment process for the removal of complex inorganic and organic contaminants in water and WW. US treatment has shown substantial advantages, such as cleanliness, safety, energy savings, and negligible or no secondary pollution products. This review provides a summary of recent research on the removal of EDCs and PPCPs by US treatment and also provides information valuable for applications of US treatment in water and WW treatment. The removal of numerous EDCs and PPCPs of different classes was reviewed based on the current literature to (i) address key factors (water quality conditions (pH, temperature, background common ions, and promoters/scavengers), US frequency, power, and reactor type) influencing the sonodegradation of EDCs and PPCPs and their intermediates during US treatment, (ii) evaluate the effects of various catalysts and hybrid processes on sonodegradation, and (iii) discuss EDC and PPCP removal according to their properties. Additionally, areas of future research in US treatment for the removal of EDCs and PPCPs from water are suggested.

KW - Endocrine-disrupting compounds

KW - Pharmaceuticals and personal care products

KW - Sonodegradation

KW - Ultrasonic treatment

KW - Water treatment

UR - http://www.scopus.com/inward/record.url?scp=85032623396&partnerID=8YFLogxK

U2 - 10.1016/j.cej.2017.06.137

DO - 10.1016/j.cej.2017.06.137

M3 - Review article

AN - SCOPUS:85032623396

SN - 1385-8947

VL - 327

SP - 629

EP - 647

JO - Chemical Engineering Journal

JF - Chemical Engineering Journal

ER -

Ultrasonic treatment of endocrine disrupting compounds, pharmaceuticals, and personal care products in water: A review

Abstract

Bibliographical note

Keywords

Access to Document

Fingerprint

Cite this